Dr Kavita B Kalra, MD | |
821 N Eutaw St, Suite 206, Baltimore, MD 21201-4648 | |
(410) 246-4450 | |
(410) 617-8326 |
Full Name | Dr Kavita B Kalra |
---|---|
Gender | Female |
Speciality | Hematology/oncology |
Experience | 25 Years |
Location | 821 N Eutaw St, Baltimore, Maryland |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063495232 | NPI | - | NPPES |
64768601 | Other | MD | BCBS |
510806300 | Medicaid | MD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RH0003X | Internal Medicine - Hematology & Oncology | D58037 (Maryland) | Primary |
Entity Name | Baltimore Oncology Hematology Associates Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1598972259 PECOS PAC ID: 4385678564 Enrollment ID: O20050927000426 |
News Archive
Molecules that selectively interfere with protein production can stop human cells from making the abnormal molecules that cause Huntington's disease, researchers at UT Southwestern Medical Center have found.
Consuming two or more soft drinks per week increased the risk of developing pancreatic cancer by nearly twofold compared to individuals who did not consume soft drinks, according to a report in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
NGM Biopharmaceuticals, Inc. and MedImmune, the global biologics research and development arm of AstraZeneca, announced today that they have entered into an exclusive agreement to discover, develop and commercialize novel therapeutics from NGM's enteroendocrine cell program for the treatment of type 2 diabetes and obesity.
Healthpoint Biotherapeutics today announced that the results for its Phase 2b clinical trial investigating the efficacy of HP802-247 in venous leg ulcers is published on The Lancet, beginning August 3, 2012, with Online First access to the article, followed by print publication in the next issue.
In its continuing initiatives around Doing What's Right, SC Johnson, A Family Company, recently announced its first commitment as part of its involvement in the Clinton Global Initiative (CGI). Founded by former President Bill Clinton in 2005, CGI brings world leaders from a variety of backgrounds together to create partnerships that result in innovative and measurable solutions to some of the world's most pressing challenges.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Kavita B Kalra, MD 821 N Eutaw St, Suite 206, Baltimore, MD 21201-4648 Ph: (410) 246-4450 | Dr Kavita B Kalra, MD 821 N Eutaw St, Suite 206, Baltimore, MD 21201-4648 Ph: (410) 246-4450 |
News Archive
Molecules that selectively interfere with protein production can stop human cells from making the abnormal molecules that cause Huntington's disease, researchers at UT Southwestern Medical Center have found.
Consuming two or more soft drinks per week increased the risk of developing pancreatic cancer by nearly twofold compared to individuals who did not consume soft drinks, according to a report in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
NGM Biopharmaceuticals, Inc. and MedImmune, the global biologics research and development arm of AstraZeneca, announced today that they have entered into an exclusive agreement to discover, develop and commercialize novel therapeutics from NGM's enteroendocrine cell program for the treatment of type 2 diabetes and obesity.
Healthpoint Biotherapeutics today announced that the results for its Phase 2b clinical trial investigating the efficacy of HP802-247 in venous leg ulcers is published on The Lancet, beginning August 3, 2012, with Online First access to the article, followed by print publication in the next issue.
In its continuing initiatives around Doing What's Right, SC Johnson, A Family Company, recently announced its first commitment as part of its involvement in the Clinton Global Initiative (CGI). Founded by former President Bill Clinton in 2005, CGI brings world leaders from a variety of backgrounds together to create partnerships that result in innovative and measurable solutions to some of the world's most pressing challenges.
› Verified 9 days ago
Dr. Leonard Anang Sowah, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 22 S Greene St, Baltimore, MD 21201 Phone: 410-706-4619 Fax: 410-706-2062 | |
Dr. Bhavandeep Singh Bajaj, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3345 Wilkens Avenue, Suite L10, Baltimore, MD 21229 Phone: 410-644-4444 Fax: 410-644-4484 | |
Dr. Yonas Sisay, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 822 Guilford Ave, #100, Baltimore, MD 21202 Phone: 410-385-9672 | |
Dr. Stephen John Witanowski, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 2700 Quarry Lake Dr, Suite 280, Baltimore, MD 21209 Phone: 410-469-5544 Fax: 410-585-2867 | |
Dr. Susrutha Kotwal, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4940 Eastern Ave, Mfl Bldg, West Tower, 6th Floor, Baltimore, MD 21224 Phone: 410-550-5018 | |
Dr. Mitesh G Trambadia, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 6701 N Charles St Ste 5218, Baltimore, MD 21204 Phone: 443-849-3786 | |
Ronak K Patel, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 201 E University Pkwy, Baltimore, MD 21218 Phone: 410-554-2000 |